1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

QBiotics Group Limited

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2004

Location

QLD Australia

Primary Industry

Biotechnology

About

Based in Australia, and founded in 2004 QBiotics Group Limited is a pharmaceutical company that provides medical treatment to prevent tumor, cancer, and chronic wound management for human and animal health. The company was co-founded by Dr. Victoria Gordon and Dr. Paul Reddell. In September 2017, QBiotics Limited merged with EcoBiotics Limited with a new holding company called QBiotics Group Limited. QBiotics Group Limited develops plant-derived cell signaling molecules to determine health problems in humans and animals. The company offers two programs in oncology and wound healing. Oncology’s products are called tigilanol tiglate designed to treat tumours across multiple species. On the other hand, a Wound healing product is called EBC-1013 designed to treat wounds including chronic non-healing and traumatic acute wounds. The company generates revenue through the sale of the developed therapies to pharmaceutical companies. The company’s future strategy includes further development of its human drug development pipeline in both oncology and wound healing and expand its market.
Current Investors
TDM Growth Partners

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.qbiotics.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.